IPO registrations (S-1, F-1) · Registrants
COMPASS Pathways plc
- SEC CIK
- 1816590 · filings on EDGAR ↗
- Former names
- Compass Rx Ltd. (2020–2020)
- Registration
- Form F-1, first filed 2020-08-28, last 2021-04-28; 2 initial registrations, 2 amendments
- Outcome
- Final prospectus filed 2020-09-21; declared effective 2020-09-17
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- X0
- Business address
- 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, Chesire, X0 WA14 2DT
- Ticker
- CMPS (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- COMPASS Pathways plc on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per ADS (F-1/A filed 2020-09-14)
- Final price
- $17.00 per ADS, above the range (424B4 filed 2020-09-21, an initial public offering)
- Shares sold
- 7,500,000
- Gross proceeds
- $127,500,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CMPS
- Lead underwriters
- Cowen (2,550,000 shares); Evercore (2,175,000 shares); Berenberg Capital Markets LLC (1,500,000 shares)
- Syndicate
- Canaccord Genuity (750,000); H.C. Wainwright (525,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: COMPASS Pathways plc EXACT (CIK (EXACT))
Filings 12
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-08-28 | F-1 | F-1 (foreign registration) | COMPASS Pathways plc | 0001628280-20-013118 ↗ |
| 2020-09-14 | F-1/A | F-1/A (amendment) | COMPASS Pathways plc | 0001628280-20-013522 ↗ |
| 2020-09-17 | F-1MEF | F-1MEF (added securities) | COMPASS Pathways plc | 0001628280-20-013726 ↗ |
| 2020-09-17 | EFFECT | EFFECT (declared effective) | COMPASS Pathways plc | 9999999995-20-002485 ↗ |
| 2020-09-17 | EFFECT | EFFECT (declared effective) | COMPASS Pathways plc | 9999999995-20-002486 ↗ |
| 2020-09-21 | 424B4 | 424B4 (final prospectus) | COMPASS Pathways plc | 0001628280-20-013779 ↗ |
| 2021-04-27 | F-1 | F-1 (foreign registration) | COMPASS Pathways plc | 0001628280-21-007756 ↗ |
| 2021-04-28 | F-1/A | F-1/A (amendment) | COMPASS Pathways plc | 0001628280-21-007924 ↗ |
| 2021-04-29 | F-1MEF | F-1MEF (added securities) | COMPASS Pathways plc | 0001628280-21-008289 ↗ |
| 2021-04-29 | EFFECT | EFFECT (declared effective) | COMPASS Pathways plc | 9999999995-21-001637 ↗ |
| 2021-04-30 | 424B4 | 424B4 (final prospectus) | COMPASS Pathways plc | 0001628280-21-008460 ↗ |
| 2022-05-03 | EFFECT | EFFECT (declared effective) | COMPASS Pathways plc | 9999999995-22-001284 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-09-14 | F-1/A | registration statement | $14.00–$16.00 | $15.00 | 6,700,000 | $100,500,000 | Nasdaq CMPS | 4 | primary document; range, price sentence, shares headline, proceeds computed, cover names 4 | document ↗ |
| 2020-09-21 | 424B4 | final prospectus | $17.00 | 7,500,000 | $127,500,000 | Nasdaq CMPS | 5 | primary document; price sentence, shares headline, proceeds table, underwriting table 5, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Camm Jason | Director | 1 | 2022 | ||
| FALVEY MICHAEL | Officer | Chief Financial Officer | 2 | 2022–2023 | |
| Goldsmith George Jay | Director,Officer,TenPercentOwner; Director,TenPercentOwner; TenPercentOwner | Chief Executive Officer | 21 | 2022–2024 | |
| Goodwin Guy | Officer | Chief Medical Officer | 6 | 2022–2026 | |
| Jenkins Annalisa | Director | 12 | 2022–2025 | ||
| Lonngren Thomas | Director | 5 | 2022–2025 | ||
| Malievskaia Ekaterina | Director,Officer,TenPercentOwner; Director,TenPercentOwner; Officer; TenPercentOwner | Chief Innovation Officer | 20 | 2022–2024 | |
| McGoldrick Linda | Director | 5 | 2022–2025 | ||
| McQuade Robert | Director | 6 | 2022–2026 | ||
| Norton David Y | Director | 7 | 2022–2026 | ||
| Riley Wayne Joseph | Director | 6 | 2022–2026 | ||
| OWENS MATTHEW A | Officer | General Counsel & CLO | 4 | 2022–2024 | |
| ATAI Life Sciences AG | TenPercentOwner | 2 | 2022–2024 | ||
| ATAI Life Sciences N.V. | TenPercentOwner | 2 | 2022–2024 | ||
| Nath Kabir | Director,Officer | Chief Executive Officer | 14 | 2022–2026 | |
| Karydas Daphne | Director | 5 | 2023–2026 | ||
| Hughes Mary-Rose | Officer | Interim CFO | 2 | 2023–2024 | |
| Loxam Teri | Officer | Chief Financial Officer | 7 | 2024–2026 | |
| SANTINI GINO | Director | 4 | 2024–2026 | ||
| Gover Justin D. | Director | 3 | 2025–2026 | ||
| JONAS JEFFREY M | Director | 3 | 2025–2026 | ||
| Tregoning Kathleen | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | COMPASS Pathways plc | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.